NEW YORK, Dec. 13, 2016 /PRNewswire/ -- The European influenza vaccines market is anticipated to reach nearly US$ 650 Million by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.
In the European influenza vaccines market, Germany accounts for majority of the market share. Italy is the second leading market for influenza vaccines in 2015. United Kingdom and France are the third and fourth leading market for influenza vaccines with XX% and XX% market share in 2015. Spain accounted for XX% share of the European influenza vaccines market in 2015. Netherlands, Ireland, Denmark, Luxembourg and Sweden are the other emerging market for influenza vaccines market.
In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.
iGATE Research report titled "Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021" provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 110 Page report contains 57 Figures and 6 Tables to present a clear picture of the influenza vaccines market.
The Influenza Vaccines Market have been analyzed from 5 viewpoints:
1. Europe Influenza Vaccines Market, Persons Vaccinated and Forecast (2011 - 2021)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2021)
3. Influenza Vaccines Brand Sales and Forecast to 2021
4. Influenza Vaccines Market - Major Deals
5. Influenza Vaccines Market - Driving Factors and Challenges
Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution
5. United Kingdom
Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases
Read the full report: http://www.reportlinker.com/p04427830-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/europe-influenza-vaccines-market-persons-vaccinated-brand-analysis-and-forecast-to-2021-300377935.html